This article is more than 5 years old. Information may no longer be current.
Infections reported after steroid injections spur product recall
Click Here to Manage Email Alerts
There have been 20 reported cases of skin and soft tissue infections after intramuscular steroid injection, according to the CDC.
The cases were reported in Illinois, North Carolina and Florida, and have been linked to 80 mg/mL preservative-free methylprednisolone acetate in 10 mL vials that were produced by the Main Street Family Pharmacy in Newbern, Tenn.
The etiology of the infections is still being investigated, but at least one of the infections appears to be fungal in nature, according to the FDA. There have been no reports of meningitis or other life-threatening illnesses.
All sterile products have been voluntarily recalled by the pharmacy. A joint investigation by the CDC, the FDA and the departments of health in Illinois, North Carolina and Tennessee is under way. Officials are advising health care providers to contact patients who potentially received an injection compounded by the pharmacy to determine whether they are experiencing symptoms of infection.
Upon reviewing records from the pharmacy, officials determined that potentially contaminated products were sent to Alabama, Arkansas, California, Florida, Kentucky, Illinois, Louisiana, Mississippi, New Mexico, North Carolina, South Carolina, Tennessee and Texas.